1,057
Participants
Start Date
August 27, 2020
Primary Completion Date
April 8, 2021
Study Completion Date
September 2, 2021
VIR-7831 (sotrovimab)
VIR-7831 (sotrovimab) given by intravenous infusion (single dose)
Placebo
Sterile normal saline (0.9% NaCl) given by intravenous infusion (single dose)
Investigative Site, Vienna
Investigative Site, Vienna
Investigative Site, Bellavista
Investigative Site, The Bronx
Investigative Site, El Agustino
Investigative Site, San Isidro
Investigative Site, Lima
Investigative Site, Huaral
Investigative Site, Smithfield
Investigative Site, Girona
Investigative Site, Granada
Investigative Site, Baltimore
Investigative Site, Asheboro
Investigative Site, Charlotte
Investigative Site, Decatur
Investigative Site, Stockbridge
Investigative Site, Atlanta
Investigative Site, Atlanta
Investigative Site, Gainesville
Investigative Site, Hialeah
Investigative Site, Pembroke Pines
Investigative Site, Miramar
Investigative Site, Pompano Beach
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Palmetto Bay
Investigative Site, Doral
Investigative Site, North Miami
Investigative Site, Miami
Investigative Site, Miami
Investigative Site, Tampa
Investigative Site, Tampa
Investigative Site, Cullman
Investigative Site, Anniston
Investigative Site, Vigo
Investigative Site, Chattanooga
Investigative Site, Columbus
Investigative Site, Mishawaka
Investigative Site, Caro
Investigative Site, Hazelwood
Investigative Site, Marrero
Investigative Site, Lake Charles
Investigative Site, Forney
Investigative Site, Mesquite
Investigative Site, Dallas
Investigative Site, Denton
Investigative Site, Houston
Investigative Site, Houston
Investigative Site, Houston
Investigative Site, Houston
Investigative Site, Humble
Investigative Site, Sugar Land
Investigative Site, Baytown
Investigative Site, Beaumont
Investigative Site, Laredo
Investigative Site, McAllen
Investigative Site, Austin
Investigative Site, El Paso
Investigative Site, Idaho Falls
Investigative Site, Mesa
Investigative Site, Tucson
Investigative Site, Santa Fe
Investigative Site, Las Vegas
Investigative Site, Las Vegas
Investigative Site, Los Angeles
Investigative Site, Los Angeles
Investigative Site, Rolling Hills Estates
Investigative Site, Northridge
Investigative Site, Oxnard
Investigative Site, Sacramento
Investigative Site, Kirkland
Investigative Site, Seattle
Investigative Site, Belo Horizonte
Investigative Site, Maringá
Investigative Site, Natal
Investigative Site, Passo Fundo
Investigative Site, Porto Alegre
Investigative Site, Porto Alegre
Investigative Site, Chapecó
Investigative Site, Campinas
Investigative Site, Santo André
Investigative Site, Vila Assuncao
Investigative Site, Sarnia
Investigative Site, Toronto
Investigative Site, Québec
Investigative Site, Bella Vista
Investigative Site, Centelles
Investigative Site, Terrassa
Investigative Site, Albacete
Investigative Site, Belfast
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Vir Biotechnology, Inc.
INDUSTRY